Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction.

Abstract:

:The administration of the selective β3 adrenergic receptor (β3AR) agonist BRL-37344 protects from myocardial ischemia/reperfusion injury (IRI), although the lack of clinical approval limits its translatability. We tested the cardioprotective effect of mirabegron, the first-in-class β3AR agonist approved for human use. A dose-response study was conducted in 6 pigs to select the highest intravenous dose of mirabegron without significant detrimental hemodynamic effect. Subsequently, closed chest anterior myocardial infarction (45 min ischemia followed by reperfusion) was performed in 26 pigs which randomly received either mirabegron (10 μg/kg) or placebo 5 min before reperfusion. Day-7 cardiac magnetic resonance (CMR) showed no differences in infarct size (35.0 ± 2.0% of left ventricle (LV) vs. 35.9 ± 2.4% in mirabegron and placebo respectively, p = 0.782) or LV ejection fraction (36.3 ± 1.1 vs. 34.6 ± 1.9%, p = 0.430). Consistent results were obtained on day-45 CMR. In conclusion, the intravenous administration of the clinically available selective β3AR agonist mirabegron does not reduce infarct size in a swine model of IRI.

authors

Rossello X,Piñero A,Fernández-Jiménez R,Sánchez-González J,Pizarro G,Galán-Arriola C,Lobo-Gonzalez M,Vilchez JP,García-Prieto J,García-Ruiz JM,García-Álvarez A,Sanz-Rosa D,Ibanez B

doi

10.1007/s12265-018-9819-8

subject

Has Abstract

pub_date

2018-08-01 00:00:00

pages

310-318

issue

4

eissn

1937-5387

issn

1937-5395

pii

10.1007/s12265-018-9819-8

journal_volume

11

pub_type

杂志文章
  • NRF2 in Cardiovascular Diseases: a Ray of Hope!

    abstract::Heart failure is a worldwide pandemic influencing 26 million individuals worldwide and is expanding. Imbalanced redox homeostasis in cardiac cells alters the structure and function of the cells, which leads to contractile dysfunction, myocardial hypertrophy, and fibrosis in chronic heart failure. Various targets and a...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-020-10083-8

    authors: Vashi R,Patel BM

    更新日期:2020-11-25 00:00:00

  • The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease.

    abstract::Chronic inflammation drives the development of atherosclerosis. Despite optimal treatment of classical cardiovascular risk factors, a substantial portion of the population has elevated inflammatory biomarkers and develops atherosclerosis-related complications, indicating that a residual inflammatory risk drives athero...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-020-09994-3

    authors: Bosmans LA,Bosch L,Kusters PJH,Lutgens E,Seijkens TTP

    更新日期:2020-03-28 00:00:00

  • Describing the cardiac components--attitudinally appropriate nomenclature.

    abstract::One of the first principles taught to medical students when they begin their study of human anatomy is that all structures within the body should be described as seen in the anatomical position. In this position, the subject is standing upright and facing the observer. The observer then views left-sided structures to ...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章

    doi:10.1007/s12265-012-9434-z

    authors: Anderson RH,Spicer DE,Hlavacek AJ,Hill A,Loukas M

    更新日期:2013-04-01 00:00:00

  • Pediatric Cardiac Care Consortium: an instrument for evidence-based clinical decision support.

    abstract::Pediatric Cardiac Care Consortium is a registry of cardiac catheterizations, surgical operations, and autopsies performed for infants, children, and adults with congenital heart disease. Four examples of use of PCCC data to evaluate variability in morphology, management, and outcomes for the procedures are described. ...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s12265-009-9091-z

    authors: Pyles LA,Hills CM,Larson VE,Moller JH

    更新日期:2009-06-01 00:00:00

  • Role of Circular RNAs in the Pathogenesis of Cardiovascular Disease.

    abstract::Circular RNAs (circRNAs) are single-strand covalently closed circular noncoding RNAs that are endogenous transcripts generated from linear precursor mRNA through a backsplicing mechanism. With the development of high-throughput sequencing technology, a number of circRNAs have been identified and proved to play key rol...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-019-09912-2

    authors: Li B,Li Y,Hu L,Liu Y,Zhou Q,Wang M,An Y,Li P

    更新日期:2020-08-01 00:00:00

  • Cell therapy for cardiovascular disease: a comparison of methods of delivery.

    abstract::The field of myocardial regeneration utilizing novel cell-based therapies, gene transfer, and growth factors may prove to play an important role in the future management of ischemic heart disease and cardiomyopathy. Phases I and II clinical trials have been published for a variety of biologics utilizing four methods o...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-010-9253-z

    authors: Dib N,Khawaja H,Varner S,McCarthy M,Campbell A

    更新日期:2011-04-01 00:00:00

  • The biological basis of thrombosis and bleeding in patients with ventricular assist devices.

    abstract::The clinical success of left ventricular assist devices (LVADs) has been tempered by significant hemorrhagic and thromboembolic complications. In the case of LVADs, where the biomaterial is in direct contact with the blood circulation, significant changes in systemic immunologic and thrombostatic functions have been w...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-008-9072-7

    authors: John R,Lee S

    更新日期:2009-03-01 00:00:00

  • Regulation of mammalian microRNA expression.

    abstract::MicroRNAs are widely expressed, approximately 22-nucleotide-long non-protein-coding RNAs. They are first transcribed as much longer primary transcripts, which then undergo a series of processing steps to yield the single-stranded, mature microRNAs. Like other classes of RNAs in a cell, the biogenesis of microRNAs is u...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-010-9166-x

    authors: Zhang X,Zeng Y

    更新日期:2010-06-01 00:00:00

  • Correction to: Sex and Gender Differences in Ischemic Heart Disease: Endocrine Vascular Disease Approach (EVA) Study Design.

    abstract::The authors of this study protocol would like to amend it and clarify that medication adherence was assessed using the 4-item validated Morisky, Green, Levine scale [Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan;24(1):67-74] r...

    journal_title:Journal of cardiovascular translational research

    pub_type: 已发布勘误

    doi:10.1007/s12265-019-09870-9

    authors: Raparelli V,Proietti M,Lenzi A,Basili S,EVA Collaborators.

    更新日期:2020-02-01 00:00:00

  • Speckle-Tracking Echocardiographic Strain Analysis Reliably Estimates Degree of Acute LV Unloading During Mechanical LV Support by Impella.

    abstract::Non-invasive means of evaluating appropriate cardiac unloading remain to be established. We hypothesized that myocardial deformation assessed by echocardiographic speckle-tracking strain analysis can reliably estimate the degree of left ventricular (LV) unloading under mechanical circulatory support. A total of 24 Yor...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章

    doi:10.1007/s12265-018-9812-2

    authors: Hammoudi N,Watanabe S,Bikou O,Ceccaldi A,Fish K,Yamada KP,Miyashita S,Lebreton G,Hajjar RJ,Ishikawa K

    更新日期:2019-04-01 00:00:00

  • Innovations in the development of cardiac resynchronization therapy devices with defibrillation capability-the Boston Scientific experience.

    abstract::Cardiac resynchronization therapy (CRT) has been clinically proven to improve symptoms, exercise capacity, and quality of life and promote reduction in ventricular dimensions. When combined with a defibrillator (CRT-D), significant reductions in all-cause mortality alone and in combination with cause-specific hospital...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章

    doi:10.1007/s12265-008-9051-z

    authors: Yong P,Deperalta E

    更新日期:2008-12-01 00:00:00

  • Maternal and neonatal exposure to environmental tobacco smoke targets pro-inflammatory genes in neonatal arteries.

    abstract::Maternal mainstream tobacco smoking is known to have adverse outcomes on fetal respiratory function; however, no data is currently available on the effects of passive exposure to tobacco smoking and environmental tobacco smoke (ETS) on fetal systemic arterial structure and function. Eight pregnant rhesus macaque monke...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章

    doi:10.1007/s12265-010-9226-2

    authors: Villablanca AC,Pinkerton KE,Rutledge JC

    更新日期:2010-12-01 00:00:00

  • Non-invasive Thoracic Impedance Changes in COVID-19 Pulmonary Infection.

    abstract::Graphical abstract. ...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章

    doi:10.1007/s12265-020-10077-6

    authors: Kapur S,Sweeney MO,Sauer W,MacRae CA

    更新日期:2020-10-13 00:00:00

  • Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19.

    abstract::COVID-19 is a syndrome that includes more than just isolated respiratory disease, as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV2) also interacts with the cardiovascular, nervous, renal, and immune system at multiple levels, increasing morbidity in patients with underlying cardiometabolic conditions and ...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-020-10031-6

    authors: Fudim M,Qadri YJ,Ghadimi K,MacLeod DB,Molinger J,Piccini JP,Whittle J,Wischmeyer PE,Patel MR,Ulloa L

    更新日期:2020-12-01 00:00:00

  • Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.

    abstract::Comprehensive diagnostic criteria, accurate prognostic indicators, and effective treatment for patients with heart failure and a preserved ejection fraction (HFpEF) represent a critically important unmet need in cardiovascular medicine. Novel approaches to fill this unmet need are likely to be facilitated by targeting...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-013-9472-1

    authors: Zile MR,Baicu CF

    更新日期:2013-08-01 00:00:00

  • Haptoglobin genotype and its role in diabetic cardiovascular disease.

    abstract::Over the past decade, several longitudinal epidemiological studies have brought attention to the haptoglobin genotype and its importance in determining diabetic vascular disease risk. This manuscript presents an overview of the biology of the haptoglobin genotype and reviews the literature concerning its role in the d...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-012-9361-z

    authors: Costacou T,Levy AP

    更新日期:2012-08-01 00:00:00

  • Serum Extracellular Vesicles Retard H9C2 Cell Senescence by Suppressing miR-34a Expression.

    abstract::Extracellular vesicles (EVs) are small-sized membrane-surrounded structures released from cells into the blood, which play important roles in regulating various biological processes. However, the role of EVs in Doxorubicin (DOX)-induced cardiomyocytes senescence remains elusive. In this study, we found that human seru...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章

    doi:10.1007/s12265-018-9847-4

    authors: Liu Y,Liu Z,Xie Y,Zhao C,Xu J

    更新日期:2019-02-01 00:00:00

  • The anatomy of the conduction system: implications for the clinical cardiologist.

    abstract::It is just over 100 years since details emerged of the anatomical arrangement of the histologically specialised cardiomyocytes responsible for initiation and propagation of the cardiac impulse. Shortly thereafter, histological criteria were established to permit their location in autopsied human hearts. These criteria...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-012-9433-0

    authors: Anderson RH,Boyett MR,Dobrzynski H,Moorman AF

    更新日期:2013-04-01 00:00:00

  • NADPH oxidase and cardiac failure.

    abstract::Increases in oxidative stress in the heart play an important role in mediating hypertrophy, apoptosis, fibrosis, mitochondrial dysfunction, and the consequent development of heart failure. Although it has been widely believed that electron leakage from the mitochondrial electron transport chain is the primary source o...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-010-9184-8

    authors: Kuroda J,Sadoshima J

    更新日期:2010-08-01 00:00:00

  • Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study.

    abstract::Intramyocardial transplantation of autologous bone marrow mononuclear cells (BMMC) is believed to be a promising method for the treatment of patients with chronic ischemic heart disease. The aim of this study was to evaluate long-term results of intramyocardial bone marrow cell transplantation in patients with severe ...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s12265-009-9123-8

    authors: Pokushalov E,Romanov A,Chernyavsky A,Larionov P,Terekhov I,Artyomenko S,Poveshenko O,Kliver E,Shirokova N,Karaskov A,Dib N

    更新日期:2010-04-01 00:00:00

  • Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.

    abstract::The second messengers, cAMP and cGMP, regulate a number of physiological processes in the myocardium, from acute contraction/relaxation to chronic gene expression and cardiac structural remodeling. Emerging evidence suggests that multiple spatiotemporally distinct pools of cyclic nucleotides can discriminate specific ...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-010-9203-9

    authors: Miller CL,Yan C

    更新日期:2010-10-01 00:00:00

  • Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading?

    abstract::The joint European Society of Cardiology and European Association of Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization collect and summarize the evidence regarding decision-making, diagnostics, and therapeutics in various clinical scenarios of coronary artery disease, including elective, u...

    journal_title:Journal of cardiovascular translational research

    pub_type: 历史文章,杂志文章,实务指引,评审

    doi:10.1007/s12265-015-9632-6

    authors: Costa F,Ariotti S,Valgimigli M,Kolh P,Windecker S,Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

    更新日期:2015-06-01 00:00:00

  • Comparison of High-Dose Rosuvastatin Versus Low-Dose Rosuvastatin Plus Ezetimibe on Carotid Atherosclerotic Plaque Inflammation in Patients with Acute Coronary Syndrome.

    abstract::We compared the effects of ezetimibe/rosuvastatin 10/5 mg versus rosuvastatin 20 mg on carotid atherosclerotic plaque inflammation measured by 18FDG PET/CT. Fifty patients with acute coronary syndrome (ACS) were randomly assigned to the ezetimibe/rosuvastatin 10/5 mg and rosuvastatin 20 mg groups. The primary outcome ...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1007/s12265-020-10009-4

    authors: Oh M,Kim H,Shin EW,Sung C,Kim DH,Moon DH,Kim N,Eo JS,Kim JW,Lee CW

    更新日期:2020-12-01 00:00:00

  • Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine.

    abstract::The goal of this paper is to provide an updated review for scientists and clinicians on the major areas in cardiovascular medicine published in the Journal. Leading topics in regenerative and personalized medicine are presented along with a critical overview of the field. New standards in large preclinical animal mode...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-015-9657-x

    authors: Barbato E,Barton PJ,Bartunek J,Huber S,Ibanez B,Judge DP,Lara-Pezzi E,Stolen CM,Taylor A,Hall JL

    更新日期:2015-11-01 00:00:00

  • Pediatric cardiac devices--an FDA pediatrician's perspective of the challenges and potential solutions.

    abstract::The advancement of pediatric medical devices is an important challenge currently facing the Food and Drug Administration and the medical community. In this manuscript, the challenges are described and possible solutions presented. ...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章

    doi:10.1007/s12265-009-9100-2

    authors: Dolcimascolo F

    更新日期:2009-06-01 00:00:00

  • Predictive Value of Circulating microRNA-134 Levels for Early Diagnosis of Acute Pulmonary Embolism: Meta-analysis.

    abstract::Acute pulmonary embolism (APE) is a common sudden venous thromboembolism with high rates of morbidity and mortality. Several studies have concluded that microRNA-134 could be a potential biomarker for APE. However, the sensitivity of these studies varies widely. This study aimed to evaluate the diagnostic value of cir...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-020-10087-4

    authors: Liu Y,Xie M,Gao X,Liu R

    更新日期:2021-01-06 00:00:00

  • The baroreceptor as a therapeutic target for heart failure.

    abstract::Sympathoactivation is a prominent feature of heart failure (HF). Its role in cardiac remodeling and arrhythmogenesis is well-recognized today, although incomplete understanding of autonomic mechanisms was a barrier to development of contemporary medical therapies. Despite widespread availability of drugs and devices, ...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-014-9546-8

    authors: Gronda E,Lovett EG,Tarascio M,Georgakopoulos D,Grassi G,Vanoli E

    更新日期:2014-04-01 00:00:00

  • Arterial stiffness in prehypertension: a possible vicious cycle.

    abstract::The pathophysiological abnormalities associated with increased arterial stiffness and/or abnormal pressure wave reflection may play crucial roles in increasing the risk of development of cardiovascular events. On the other hand, prehypertension, defined as a systolic blood pressure of 120-139 and/or a diastolic blood ...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-011-9345-4

    authors: Tomiyama H,Yamashina A

    更新日期:2012-06-01 00:00:00

  • Plasma Ceramides in Relation to Coronary Plaque Characterization Determined by Optical Coherence Tomography.

    abstract::Plasma ceramides (Cer), a subset of bioactive lipids, have mechanistic links to development of atherosclerosis and are related to major adverse cardiovascular events (MACEs). Previous researches have demonstrated vulnerable plaques contribute to acute cardiovascular events and poor prognosis. This study aimed to explo...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章

    doi:10.1007/s12265-020-09978-3

    authors: Pan W,Dong H,Sun R,Zhao L,Sun M,Li L,Yu X,Liu J,Wu J,Yang F,Yu B

    更新日期:2020-03-24 00:00:00

  • Platelet function testing in patients with acute coronary syndrome.

    abstract::In patients with an acute coronary syndrome (ACS), inhibition of the platelet P2Y12 receptor is standard of care. The shortcomings of the most commonly used P2Y12 receptor inhibitor clopidogrel-that is its delayed onset of action, its interindividual response variability, and the phenomenon of high on-treatment platel...

    journal_title:Journal of cardiovascular translational research

    pub_type: 杂志文章,评审

    doi:10.1007/s12265-013-9450-7

    authors: Orban M,Sibbing D

    更新日期:2013-06-01 00:00:00